Column
Pharmacology Consult
July 31, 2026
7 min read
Add topic to email alerts
Despite advances in medical therapy to decrease morbidity and mortality in heart failure with reduced ejection fraction, age-adjusted mortality rates in 2021 were higher than in 1999, and rates of hospitalizations have increased since 2014. This highlights the ongoing need for optimizing patient care through improved prescribing of guideline-directed medical therapy (GDMT). The four pillars of
Column
Pharmacology Consult
July 31, 2026
7 min read
Add topic to email alerts

An update to the previously published multispeciality guide for the management of diabetes, cardiorenal and metabolic diseases…

Since the introduction of durable left ventricular assist devices for advanced heart failure, management of antithrombotic…

Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart failure…

PHILADELPHIA — Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that…

Recent data reveal a striking paradox: While 73% of endocrinologists prescribe glucose-lowering medications, fewer than 10% of…

PHILADELPHIA — With combination therapies and multiple treatment options available for patients, nephrology is in a “therapeutic…